Objective: The vitamin-A derivative all-trans retinoic acid (atRA) is a potent regulator of cell growth, differentiation, and matrix formation of various cell types and plays an important role in embryogenesis. However, sparse data are available about its effects on human vessel diseases. Thus, we studied the effects of atRA on human arterial smooth muscle cell (haSMC) and endothelial cell (haEC) proliferation, migration, differentiation and extracellular matrix (ECM) turnover in mono-and transfilter cocultures. Methods: Effects of atRA on human arterial cells in monocultures were determined using cell counting assays, BrdU-ELISA and MTT-tests. In transfilter cocultures haSMC-growth was studied under the stimulatory effect of proliferating haEC. Using Northern blot analysis, effects of atRA on mRNA expression of ECM-proteins were examined while protein expression and activity of matrix metalloproteinases were determined by Western blotting and zymography. Results: atRA caused a dose dependent inhibition of haSMC-growth in monocultures (IC at 0.022 50 mM) whereas haEC-growth was inhibited less potently (IC at 97 mM). In addition, proliferation and migration of haSMC through a 50 porous membrane were inhibited dose dependently by micromolar atRA-doses after non-stop and single dose application of atRA on the endothelial side of the complex transfilter coculture system. Immunostainings and Northern blotting demonstrated an enhanced a-smooth muscle actin and heavy chain myosin expression in haSMC after atRA-treatment. Whereas mRNA-expression of the glycoproteins thrombospondin-1 and fibronectin were decreased, collagen-1 mRNA expression was even slightly stimulated. Transcription of biglycan and TGF-b1 were not influenced in a specific manner. Finally, protein expression and activity of the matrix metalloproteinases MMP-2 and MMP-9 were inhibited significantly by atRA. Conclusions: atRA was found to be a potent inhibitor of both haSMC-proliferation and -migration, even in coculture with haEC releasing growth factors. In addition, redifferentiation, ECM synthesis and ECM degradation were regulated by atRA which also influence haSMC migration and intima formation. Thus, atRA-treatment seems to be a promising strategy for the inhibition of processes involved both in atherosclerosis and restenosis.
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Introduction
ventions is still unsolved [3] . Although very potent anti-® mitotic agents, such as paclitaxel (Taxol ), have been used Despite numerous in vitro and in vivo studies with a showing very efficient inhibitory effects on smooth muscle great variety of pharmacological compounds exerting cells in vitro [4] and in animal studies using local drug growth inhibitory effects on smooth muscle cells (SMC) devices [5] , efficacy in human coronary arteries has not [1] [2] [3] [4] , the problem of restenosis after percutaneous interbeen shown so far [6] . Beside proliferation of smooth muscle cells, migration, phenotypic differentiation, as well as extracellular matrix (ECM) formation and degradation determine the extent of intimal thickenings [7] . The 2. Methods predominant feature of late restenotic lesions is a large amount of extracellular matrix with a reduced number of 2.1. Cell isolation and culture smooth muscle cells, whereas in the early stages of intimal thickening formation the number of SMC is increased [8] .
Human arterial smooth muscle cells (haSMC) and To successfully interfere with and modulate these proendothelial cells (haEC) were isolated from specimens of cesses, compounds are necessary which exert multifactorihuman iliac arteries which were discarded after liver al effects on cellular activation and expression of extraceltransplantations, as described previously [19] . After melular matrix constituents. Thus, a single antiproliferative chanical removal of haEC, subcultivation was performed approach for the prevention of restenosis, as performed in in gelatine-coated (Sigma, Deisenhofen, Germany) plastic most human trials until now [9] , seems to be not very flasks using the modified EGM-2 BulletKit. It consists of promising.
the basal medium CCMD-130 and the following suppleRetinoids are derivatives from vitamin A and are ments: hydrocortisone (0.04%), fetal bovine serum (2.0%), involved in a number of biological processes, e.g. vision, vascular endothelial growth factor (VEGF, 0.1%), human embryogenesis, cell differentiation of blood cells, as well recombinant epidermal growth factor (hEGF, 0.1%), long as of skin and tumor cells [10] . Therefore, retinoids are recombinant 3-insulin-like growth factor-1 (R3-IGF-1, clinically used in oncology, predominantly against acute 0.1%), hFGF-B (w / heparin, 0.4%), but without heparin, promyelocytic leukemia [11] and hyperproliferative skin ascorbinic acid and antimycotics (CellSystems, Freiburg, diseases [12] . Moreover, retinoids were found to inhibit Germany). haSMC were obtained using the explant techinflammation [12] , thrombosis [13] , platelet adhesion and nique. Subcultivation of haSMC was performed in plastic aggregation [14] and stimulate fibrinolysis [15] . Predomiculture dishes with Waymouth's MB 752 / 1 and nutrient nantly all-trans retinoic acid (atRA) and its stereoisomer mixture Ham's F12 (111), supplemented with 10% fetal 9-cis retinoic acid (9cRA) were found to be very potent calf serum (FCS, PAA Laboratories, Colbe, Germany), 100 metabolites of retinol exerting pleiotropic effects on many U / ml penicillin and 100 mg / ml streptomycin (Gibco different biological processes [16] . Previous in vitro-BRL). studies using rat aortic SMC showed that atRA inhibits
Immunocytochemical stainings with specific antibodies platelet-derived growth factor-BB and serum-induced SMC against a-smooth muscle actin (Progen, Heidelberg, Gergrowth. These effects most probably were mediated by five many) and the von Willebrand factor (Boehringer Mannof six retinoid receptors which were expressed by these heim, Germany) were used to prove smooth muscle cell vascular SMC [17] . In addition, the first in vivo study in and endothelial cell origin, respectively. Microscopic rat carotid arteries demonstrated that atRA reduces neointiobservations showed the characteristic 'hill and valley' mal thickening and favors remodeling after endothelial growth pattern and the 'cobblestone' growth pattern, denudation [18] .
respectively. To avoid immune reactions, both cell types The current experience with atRA has been achieved in were isolated from the same vessel specimen of the same vitro and in vivo with rat aortic smooth muscle cells which donor and used in the first three passages. Routine do not allow direct comparison to SMC of human origin.
stainings with the DNA dye DAPI (49,6-diamidino-2-Furthermore, the high dose of atRA (30 mg / kg per day) phenylindole-dihydrochloride; Boehringer Mannheim) administered into rats might induce severe side-effects in were used to exclude mycoplasm contaminations [4] . humans. Thus, the aim of our study was to analyze the effects of atRA on human arterial smooth muscle (haSMC) 2.2. Test compound and endothelial cell (haEC)-proliferation and -migration in a transfilter coculture system in which local application of All-trans retinoic acid was purchased from Sigma compounds on the endothelium in a broad concentration (Deisenhofen, Germany), dissolved in pure ethanol to a range can be examined in detail [19, 20] . These growth stock solution of 10 mM, and sterile-filtered. All preparastudies were extended by examination of the effects of tions were performed under light protection and prepared atRA on phenotypic haSMC-differentiation, on the synfreshly prior to each application. In order to obtain thesis of four extracellular matrix constituents, and finally different test concentrations between 0.1 mM and 0.1 nM, on the degradation of ECM-proteins by matrix metalloserial dilutions of this stock solution were prepared with proteinases (MMPs). The ECM in the vascular wall culture medium. The vehicle ethanol was also analyzed includes proteoglycans and fibrous proteins. The latter are separately for antiproliferative or cytotoxic effects in classified into two categories: structural (collagen and equivalent concentrations. elastin) and adhesive molecules (laminin, thrombospondin, fibronectin [4] . Final cell numbers were also tion and detection techniques with digoxigenin-labeled determined 24 h after the last medium change and addition probes were performed according to our previously deof atRA using a cell counter. Each concentration was scribed methods [22, 23] . Hybridization solutions (10 ng tested in a total of six wells and repeated twice.
cDNA / 10 ml) of the following cDNA combinations were used (resulting band in parenthesis): human 2.3.2. Transfilter coculture system thrombospondin-1 (TSP-1, 7.0 kb; a gift from Dr Jack Cocultures using the transfilter system were prepared Lawler, Boston) and human TGF-b1 cDNA (2.4 kb; according to techniques previously described [21] .
ATCC shown previously [19, 20] . Then, increasing atRA doses density of 20,000 cells / cm . Cells were allowed to attach were added to the lower compartment (endothelial side) and spread overnight. Then, cultures were serum depleted non-stop or for 24 h in order to imitate local drug for 24 h because fetal calf serum per se possesses application at the 'luminal side' of an arterial vessel [4, 20] . gelatinolytic activity. Then, increasing doses of atRA Culture media were then replaced by normal, drug-free (0.01-100 mM) were added. After 6 h haSMC were medium, which was renewed every 3rd day. After 14 days, stimulated with phorbol myristate acetate (PMA, 100 ng / cell numbers on each filter side were determined separately ml, Sigma) or tumor necrosis factor (TNF-a, 10 ng / ml; after 14-day cocultivation by cell counting after disaggre-R&D Systems). Supernatants were collected after 12, 24, gation with trypsin / EDTA, and compared to controls 48 and 72 h and concentrated with Centrisart-C 30 which were treated with equivalent concentrations of the columns (Sartorius). Samples were normalized for total vehicle ethanol [4] . Each concentration was tested in a protein using the Bradford assay with bovine serum total of three cocultures.
albumin (BSA) as standard.
Immunocytochemical stainings 2.6.1. Western blot analysis
Samples of 15 mg / lane and 10 ng marker / lane (PrehaSMC were seeded on sterile coverslips and atRAstained Protein Molecular Weight Marker, Gibco BRL Life treated as described above. After 7 days, cells were fixed Technologies) were subjected to 15% SDS-PAGE in a modification of the method described by Laemmli (1970) corresponding GAPDH cDNA signal using the MDS [24] with the addition of mercaptoethanol (reducing conImageMaster Software (Gibco / Kodak). ditions) [25] . After transfer to a nitrocellulose membrane ® 2.8. Statistics (Hybond C , Amersham) and blocking, membranes were incubated for 1.5 h with the monoclonal anti-human MMPAll values are expressed as mean6S.E.M., whether in 2 or MMP-9 antibodies (both from R&D Systems) and the numbers or charted. Differences between groups were control protein MMP-9 (Calbiochem). Detection was perassessed by unpaired t-test (2 groups) or one-way ANOVA formed using a secondary horseradish peroxidase-linked (.2 groups). Subsequent multiple comparisons for $3 anti-rabbit antibody (1:500 in blocking buffer) and the ® groups were performed only if one-way ANOVA reached ECL chemiluminescence system (Amersham).
statistical significance (P,0.05) using the Student-Newman-Keul's test to compare all pairs or Dunnett's post test 2.6.2. Zymography to compare each group against control. All data satisfied Samples (40 ml / lane) underwent SDS-PAGE at 48C in the requirements of normally distributed samples of equal 7.5% polyacrylamide gels containing 2 mg / ml gelatine number between groups. Differences between means were (Sigma). SDS was then removed by rinsing twice with considered statistically significant if P,0.05 and highly 2.5% Triton X-100 (Sigma). For enzyme activation, gels significant if P,0.01. were incubated overnight at 378C with incubation buffer containing 50 mM Tris, 10 mM CaCl , 0.05% Brij, pH counting assay performed at haSMC (Fig. 1a) resulted in in transfilter cocultures in a stimulatory fashion by the an IC of 0.022 mM and an IC of 10.0 mM. At this secretion of growth factors [19, 21, 22] . Based on these 50 max specific maximum inhibitory concentration of 10.0 mM, a findings, effects of atRA on haSMC-proliferation and more than 60% growth inhibition was observed -migration in coculture with proliferating haEC were (38.0262.76%, P,0.01) compared to controls evaluated (Fig. 2) . haSMC of controls reached confluence (100.064.36%). This value measured at day 7 demon-5-7 days after seeding. Non-stop application of increasing strated a nearly complete growth inhibition when comatRA-doses into the lower (haEC)-compartment for 14 pared to the 'baseline value at day 1'. The dramatic days reduced cell numbers on both filter sides dose decrease of the curves at the highest dose of 100.0 mM dependently. Significant effects for haSMC-proliferation (4.0663.95%) below the 'baseline values at day 1' were found at doses $0.1 mM and for haSMC-migration indicated that additional unspecific cytotoxic or apoptotic even at much lower doses $0.001 mM (P,0.01 versus effects overlapped the specific inhibition. controls). The IC for haSMC-proliferation and -migration 50 To determine mitotic index of haSMC after 7 days, was determined at micromolar to nanomolar atRA-doses BrdU-ELISA were performed comparing non-stop with single dose (24 h) application of increasing atRA-concentrations (Fig. 1b) . After non-stop application, the IC , 50 determined at 0.05 mM, was found in a comparable concentration range as described for the cell counting assay. Shortening of the application time (24 h), however, resulted in a shift of the inhibition curves towards higher concentrations (Fig. 1b) which was reflected by an increased IC of 20.0 mM.
50
As also shown in Fig. 1a , the inhibition curve of haEC runs in parallel to the haSMC-curve but the total curve was shifted toward higher atRA-doses. The percentage difference of two consecutive values on the haEC-curve compared to the haSMC-curve was nearly identical. However, the absolute inhibitory effect of each atRA-concentration on haEC-growth was less potent than on haSMC-growth (a difference of |20-30%) which was also demonstrated by the increased IC of 97.0 mM which was more than three 50 orders of magnitude higher than that found for haSMC. The maximum specific inhibitory effects were measured at 100.0 mmol. In contrast to the very strong specific inhibition of haSMC (62%) at 10.0 mM, the inhibition of haEC at this dose was just 28% (72.0265.77 vs. 100.061.91%) and at the highest dose of 100.0 mM only 50% (49.7663.95%). Even at 100.0 mM, the values did not fall below those measured as baseline values at day 1. Moreover, a slight stimulatory effect was induced by 0.1-1.0 nM atRA. MTT-tests (Fig. 1c) and microscopic observations (data not shown) demonstrated that exclusively the highest test concentration of 100.0 mM exerted additional cytotoxic effects on haSMC resulting in some cell rounding and detachment. Comparable to the cell counting assays and the BrdU-ELISA, MTT-tests demonstrated that the values at 100.0 mM were significantly below the baseline values at day 1 indicating some cell loss. The IC 50 for the mitochondrial activity of haSMC was determined at 
striking application of atRA stimulated haEC-growth on the endoincrease in both a-smooth muscle actin and heavy chain thelial side first at low doses #0.1 mM whereas haSMCmyosin formation. The total number of cells stained migration was inhibited just slightly. After application of positively was increased compared to controls, but also the concentrations $1.0 mM, both haSMC-proliferation and density of intracellular filaments within each single cell -migration were inhibited significantly. In comparison to was augmented (Fig. 3) . Accordingly, Northern blot the IC after non-stop incubation, the IC for haSMCanalysis after 48 h demonstrated an increase of a-smooth 50 50 migration after single dose application was shifted toward muscle actin mRNA-expression, predominantly at lower higher micromolar atRA-doses (1.6 mM). Cell numbers, nanomolar atRA-doses (between 0.0001 and 0.01 mM) however, did not fall below those seeded at day 1 whereas at higher micromolar doses the stimulatory effects indicating that atRA exerted no significant cytotoxic were less pronounced (Fig. 4d) . This phenomenon might effects on cocultures. These results were confirmed by be due to some unspecific cytotoxicity overlapping the immunohistologic examinations after double stainings with specific effects slightly. At 100.0 mM, it was not possible specific antibodies against the von Willebrand factor and to isolate sufficient amounts of total RNA. a-SM-actin. Control cultures showed a multilayer (five to six layers) of haSMC on the lower filter side which was 3.4. Effects of atRA on mRNA expression of ECM covered by a single confluent endothelial cell lining. After proteins treatment with 1.0 mM atRA, the multilayer was reduced significantly on two to three layers whereas the endothelial Incubation of subconfluent haSMC with atRA in incell lining was still intact.
creasing concentrations for 48 h resulted in a dose dependent inhibition of thrombospondin-1 (TSP-1) mRNA-ex-3.3. Effects of atRA on cytoskeletal filament formation pression with significant effects at atRA doses $0.1 mM (Fig. 4a) determined by densitometric evaluation. These Immunofluorescence stainings of haSMC treated with results correspond with the dose-dependent inhibition of atRA on haSMC-proliferation, as shown in Fig. 1 . The slight differences in the level of the bands (they are not all mRNA-expression of the second glycoprotein fibronectin in a straight line across the gel) were caused by technical was also inhibited, but the effect was less pronounced as problems with the running of the gel. Supernatants were shown for thrombospondin-1 (Fig. 4c) . Furthermore, TGFexamined after 12-, 24-, 48-and 72-h cultivation time. b1 and biglycan mRNA-expression were not influenced by Unstimulated haSMC constitutively secreted MMP-2 but atRA (Fig. 4a,b) . Collagen-1 was inhibited exclusively at not MMP-9. Significant gelatinolytic activity (Fig. 5a , very high atRA-doses between 10.0 and 100.0 mM (Fig. lower lanes) and protein expression (Fig. 5a , upper lanes) 4b), which might be also the result of overlapping toxic of MMP-9 was found after $12-h stimulation with phorbol effects reducing cell numbers, as shown in Fig. 1 . In ester (PMA). In contrast to PMA, TNF-a did not induce contrast to thrombospondin-1 and fibronectin, a slight gelatinolytic activity (Fig. 5b ) and protein synthesis (Fig. stimulatory effect on collagen-1 mRNA expression was 5c) of MMP-9 in haSMC significantly after 24-or 72-h found in lower doses between 0.01 and 0.1 mM.
incubation. Preincubation of haSMC with atRA 6 h prior to the 3.5. Effects of atRA on MMP-2 and MMP-9 synthesis stimulation with PMA resulted in a dose dependent inhibition of the gelatinolytic activity, as well as protein SDS-PAGE zymography analysis was performed on expression of MMP-9 in a concentration range between haSMC monocultures in order to study synthesis of the 0.01 and 100.0 mmol / l which was found first 12 h after metalloproteinases MMP-2 and MMP-9 which can be stimulation with PMA ( Fig. 6a) and which persisted for up identified by their gelatinolytic activity. Furthermore, to 72 h ( Fig. 6b-d) . Western blotting demonstrated also an protein synthesis was analyzed by Western blotting. The partial inhibition of MMP-2 synthesis at highest atRA- doses between 10.0 and 100.0 mM, predominantly after 24, were two orders of magnitude lower than described for 48 and 72 h (Fig. 6b-d) , whereas zymography showed a animal SMC. In rat SMC, a 50% inhibition was found at remarkable inhibition of enzymatic activity already at 2.0 mM atRA after serum depletion and restimulation with lower atRA-doses $1.0 mM.
PDGF-BB [17] , endothelin [27] or 10% serum [28] . The difference in IC indicates that human SMC react more 50 sensitive than rat cells [26] when identical growth assays 4. Discussion were used. The effect of atRA was less pronounced in haEC when compared to haSMC, and at lower atRA-doses This in vitro study provides for the first time combined between 0.0001 and 0.001 mM even a slight growth data about the effects of all-trans retinoic acid on human stimulatory effect could be observed. This is of special arterial smooth muscle cell proliferation, migration, difimportance for clinical application of atRA to prevent ferentiation, ECM-synthesis and ECM-degradation. The restenosis since selective inhibition of haSMC-proliferation advantage of the used monocultures and cocultures is that without influencing endothelial regrowth is advantageous primary cultures isolated from human arteries were used in [29] . In addition, after single dose application of atRA the very early passages to preserve most of the in vivo inhibition curve was shifted towards higher atRA-doses. properties of normal arterial cells in humans [19, 20] . The Thus, for a single local application of atRA higher doses transfilter coculture model was developed to imitate the have to be considered to achieve comparable effects as morphology of the arterial vessel wall allowing cell-to-cell after non-stop application. interactions by the secretion of PDGF-AB, TGF-b1 and
When atRA was applied non-stop to the endothelial side other mediators [21, 22] .
of transfilter cocultures for 14 days, a dose dependent First, the results with monocultures showed a dose inhibition of haSMC-proliferation on the opposite filter dependent inhibition of haSMC-proliferation after non-stop side was found. An explanation for the higher IC 50 incubation with 0.001-10.0 mM atRA. This inhibition was compared to monocultures might be that to reach the target uniformly found in all three independent assays used. In cell, namely the haSMC-multilayer, atRA must cross the addition, analysis of mitochondrial activities indicated that endothelial cell lining and the filter pores. Obviously, only the highest dose of 100.0 mM atRA exerted unspecific part of the applied atRA dosage could indeed reach target toxic or apoptotic effects on haSMC which overlap the cells. Furthermore, haSMC-migration from the upper to the specific growth inhibitory effects. The IC after 7 days lower filter side towards the endothelial cell lining can be analyzed additionally and resembles migration of haSMC cultures, the IC was two to three orders of magnitude 50 from the media to the intima in vivo. The total of cell higher after single dose application. It is of interest that numbers counted on the endothelial side resulted from also in the transfilter coculture model haEC-growth was haEC seeded at day 1 and haSMC which were migrated stimulated by nanomolar atRA-doses (0.001-0.01 mM). from the opposite filter side after paracrine stimulation by Since proliferating haEC stimulate haSMC-migration [19-the secretion of growth factors from haEC. About 3 days 21], low atRA-doses #0.1 mM seem to be not potent after seeding, haEC formed a confluent monolayer and enough to inhibit haSMC-migration significantly. If higher stopped growing. Following this stage, the increase of cell doses were used or if the drug was applied non-stop, the numbers during the next 11 days was caused exclusively drug accumulated or the effects were additive. Interestingby migration of haSMC from the opposite filter side. Thus, ly, we found in previous studies that the vehicle ethanol in the determination of final cell numbers after 14 days concentrations according to those used to prepare atRAmainly represented the result of haSMC-migration. The dilutions (0.001-10.0 mM which corresponds to¯0.0004-adequacy of this procedure was confirmed by immuno-0.4% (v / v) ethanol) stimulated haEC-proliferation [4] . histochemical examinations indeed showing five to six Thus, the weaker inhibitory effects of nanomolar atRA layers of haSMC on the lower filter side which were doses after single dose-application might be partially covered by a confluent endothelial cell lining, as also counterbalanced by stimulatory effects of ethanol. Taken described previously [19] [20] [21] . After treatment with 1.0 mM together, the coculture results again underline the imporatRA, the multilayer was reduced significantly on two to tance of the use of a more complex coculture model as a three layers whereas the endothelial cell lining was still prescreening experimental setup before moving to in vivo intact. After both non-stop incubation and single dose studies. application, haSMC-migration was inhibited by much
In contrast to our results, Neuville et al. (1999) found lower atRA doses than those needed for the inhibition of increased migration of rat aortic smooth muscle cells after haSMC-proliferation. However, as described for monoadministration of atRA, whereas matrix metalloproteinases migration in the intima or plaque would be expected.
Whereas an increased matrix deposition may be positive for the stabilization of advanced fibrous plaques avoiding probably acute plaque rupture, the increase of extracellular matrix in restenosis would be negative because it contributes to intimal thickening. However, Northern blot analysis showed additionally that specific extracellular matrix proteins were either inhibited or stimulated by the addition of atRA. Collagen-1 expression was slightly upregulated by the treatment with nanomolar doses of atRA whereas thrombospondin-1 and fibronectin mRNA expression were inhibited dose dependently. However, the inhibition of fibronectin was not as strong as found for thrombospondin-1 which corresponds to the results of Riessen et al. (1999) showing that statins inhibited thrombospondin-1 but not fibronectin mRNA [23] . Thus, fibronectin mRNA expression seems to be more stable than thrombospondin-1 mRNA expression, even after treatment with multipotent drugs. The expression of the small chondroitin / dermatan sulfate proteoglycan biglycan was not altered by atRA. The inhibition of the glycoprotein thrombospondin-1 is of special interest because it was found to act as a mitogen for smooth muscle cells and also stimulate cell migration [32] . Furthermore, it is an activator of TGF-b1, a growth factor which inhibits haSMC growth, as we demonstrated previously [22] . Thrombospondin-1 influences plasmin formation by a complex formation with plasminogen which contributes -in a synergistic manner with MMPs -to ECM degradation and smooth muscle cell migration.
In addition, thrombospondin-1 was found to inhibit MMP activity by preventing activation of the MMP-2 and MMP- fluences, through interaction with integrins, motility, differentiation, and many of the cellular responses associated were down-regulated. In addition, ECM components were with wound healing and vessel diseases [34] . Relevant found to be activated which is consistent with our studies amounts of collagen-1 and the small proteoglycan biglycan [28] . The discrepancy with regard of migration may be due are expressed much later [35] . Abundant collagen-1 formato the species-related differences between human and rat tion is characteristic for advanced atherosclerotic lesions cells and due to the use of different culture systems. The and contributes to the stabilization of the fibrous cap [23] . inhibition of haSMC-migration in our transfilter coculture
In accordance with this finding, Hayashi et al. (1995) model was found to be accompanied by a dose dependent described that atRA also causes an increase of elastin inhibition of MMP-9 expression and activity. Gelatinases synthesis [36] . Since fibrous proteins of the ECM can be are known to degrade a variety of ECM proteins, such as classified within two categories, structural (collagen, elasnon-fibrillar collagens, proteoglycans, and elastin [30] . tin) and adhesive molecules (laminin, thrombospondin, Since smooth muscle cells in transfilter cocultures are fibronectin), our results indicate that structural proteins embedded in a voluminous matrix [19] which might in part seem to be stimulated by atRA whereas adhesive molebe comparable to fibromuscular tissue in vivo [31] , degracules are inhibited. Finally, the expression of the growth dation of those matrix proteins is probably the first step factor TGF-b1 which was found to stimulate the synthesis before cell migration occurs. Consequently, by the applicaof a variety of ECM-proteins [31] and inhibit SMCtion of atRA a corresponding increase in matrix deposition proliferation [22] was not changed by atRA. Thus, stimulaand a decrease of cell numbers after inhibition of cell tion of collagen-1 expression by atRA is not the result of an primary effect on TGF-b1 expression. These results during the next 16 h with a half-life of 2 h which might reflect induction of atRA-metabolizing capacity or saturashow that atRA exerts pleiotropic effects on vascular cells tion kinetics because incubation with 20 nM atRA showed and that the total amount of matrix and the net effect of a monophasic disappearance with a half-life of 1.4 h [40] . atRA depends on a variety of different factors.
However, despite the rapid elimination of atRA, there is In addition to these effects, haSMC-differentiation was striking in vitro and clinical activity after treatment of influenced by atRA. Previously, we found, in accordance APL-patients with atRA indicating that also lower rest with Patel et al. (2000) , that under normal culture condoses in the nanomolar range present after metabolization ditions a-smooth muscle actin mRNA and protein synmight be sufficient to inhibit vascular cell growth or that thesis are suppressed in actively proliferating SMC isolated active metabolites are formed which contribute to the from iliac arteries and increase again as the cultures effects of the parent drug atRA. Finally, for the prevention become confluent and cell replication ceases [37] . Thus, of restenosis atRA might be applied locally by the use of a-smooth muscle actin expression depends on the growth porous balloons or stents which allows the use of higher rate and cell density, as also described by others [38] . The doses as after oral application without side-effects. present study showed that atRA caused an increase in There are only sparse data available regarding the smooth muscle a-actin and heavy chain myosin protein underlying mechanisms by which atRA elicits its effects content in actively proliferating cultures. Furthermore, on vascular cells. Previously, Miano et al. (1996) showed nanomolar atRA-doses stimulated a-smooth muscle actin that five of the six nuclear retinoid receptors (RAR-a, -b, mRNA-expression whereas the increase at higher mi--g and RXR-a, -b) were expressed in rat aortic SMC and cromolar doses was reduced by overlapping cytotoxic that atRA might bind and activate the expression of at least effects reducing cell numbers slightly, as also described for the RAR-b receptor [17] . We were able to detect the five collagen-1 mRNA expression. We conclude that atRA nuclear receptors RAR-a, -b, -g and RXR-a, -b on might be beneficial for the stabilization of the fibrous cap haSMC by RT-PCR which were expressed to different by the stimulation of haEC and haSMC differentiation extents (unpublished data), but further work is needed to toward a non-activated, fully differentiated phenotype elucidate the exact mechanisms after binding of retinoids which is commonly associated with vascular cells residing to these receptors. in the normal media and in the fully differentiated fibrous
In conclusion, we have demonstrated that atRA exerts cap of advanced lesions [39] . Non-activated, highly difpleiotropic effects on a variety of processes involved in the ferentiated cells are not capable of synthesizing matrix formation of advanced atherosclerotic lesions as well as in degrading proteins. Thus, they cannot contribute to the restenosis, whereas most other compounds studied previweakening of the plaque. As a consequence, the stabilizaously were only capable of inhibiting one step, e.g. tion of the fibrous cap increases which is supported by the accelerated smooth muscle cell growth. Further in vitro direct inhibition of MMP-2 and MMP-9 synthesis in and in vivo studies are required to prove the toxicity and haSMC and by the increase in collagen-1 synthesis after efficacy of atRA after clinical applications against arterial atRA-treatment.
vessel diseases to elicit the systemic and local cellular An important question is if the described effective in mechanism of the classical vitamin-A derivative atRA and vitro concentrations of atRA can be achieved in vivo.
to develop potentially more receptor-specific, non-toxic Unfortunately, both the in vivo and in vitro half-lives synthetic derivatives. determined for atRA are relatively short. Miundi et al. (1992) reported in APL-patients that after a single oral 2 dose of 45 mg / m atRA, the C in plasma was reached pmax
